Literature DB >> 32304193

Investigation the potential use of silver nanoparticles synthesized by propolis extract as N-acyl-homoserine lactone-mediated quorum sensing systems inhibitor

Sedef Ilk1, Gamze Tan2, Ezgi Emül3, Necdet Sağlam3.   

Abstract

Background/aim: Quorum sensing (QS) is a chemical communication process that bacteria use to regulate virulence. Inhibition of QS (antiQS) overcomes the pathogenicity of bacteria. Silver nanoparticles (AgNPs) have been used as antimicrobials against pathogens, but have not been used against QS-mediated bacterial infection. Also, studies have been carried out on the inhibitory effects of propolis based structures on pathogen growth, but no studies have been found on their potential use as QS inhibitor. The present study aims to investigate the synthesis and characterization of silver nanoparticles (AgNPs) reduced with propolis extract (P–AgNPs) and evaluation of their antimicrobial and, for the first time, antiQS activity. Materials and methods: P–AgNPs were synthesized using with different volumes (1, 2.5 and 5 mL) of propolis extract (PE) by biological method via reduction of silver nitrate. Synthesized P–AgNPs were characterized in terms of hydrodynamic, chemical, morphological, physical, and antioxidant properties. Disc diffusion and flask incubation assays were used to evaluate the antimicrobial effect against Gram–negative bacteria (Escherichia coli, Proteus mirabilis,Proteus vulgaris,Salmonella typhimurium, Enterobacter aerogenes, Pseudomonas aeruginosa) and Gram–positive bacteria (Staphylococcus aureus, Streptococcus mutans, Bacillus thuringiensis) and QS–regulated biofilm activity against biosensor strain Chromobacterium violaceum CV026.
Results: AgNPs were successfully synthesized by biological method via PE. The violacein pigment production based on the QS system was greatly inhibited by the P–AgNPs (inhibition zones: 16.22-21.48 mm and violacein inhibition: 63.16 ± 2.4-75.24 ± 3.5 %) without interfering with the growth of bacteria, which is the first report on the antiQS effect of P–AgNPs.
Conclusion: Our results suggest that P–AgNPs may be potentially used to inhibit bacterial physiological processes due to the signal molecules regulates important collective behavior of bacteria. The development of such nontoxic biomaterials may have great potential to evaluate for the new medicinal substance that inhibits the pathogenic biofilms. This work is licensed under a Creative Commons Attribution 4.0 International License.

Entities:  

Keywords:  silver nanoparticles; quorum sensing; virulence factor; antimicrobial agent; propolis

Year:  2020        PMID: 32304193      PMCID: PMC7379411          DOI: 10.3906/sag-2004-148

Source DB:  PubMed          Journal:  Turk J Med Sci        ISSN: 1300-0144            Impact factor:   0.973


  23 in total

Review 1.  Bacterial communication ("quorum sensing") via ligands and receptors: a novel pharmacologic target for the design of antibiotic drugs.

Authors:  Robert B Raffa; Joseph R Iannuzzo; Diana R Levine; Kamal K Saeid; Rachel C Schwartz; Nicholas T Sucic; Oksana D Terleckyj; Jeffrey M Young
Journal:  J Pharmacol Exp Ther       Date:  2004-11-04       Impact factor: 4.030

Review 2.  Quorum sensing: cell-to-cell communication in bacteria.

Authors:  Christopher M Waters; Bonnie L Bassler
Journal:  Annu Rev Cell Dev Biol       Date:  2005       Impact factor: 13.827

Review 3.  Quorum sensing inhibitors as anti-biofilm agents.

Authors:  Gilles Brackman; Tom Coenye
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

Review 4.  Potential virulence factors of Proteus bacilli.

Authors:  A Rózalski; Z Sidorczyk; K Kotełko
Journal:  Microbiol Mol Biol Rev       Date:  1997-03       Impact factor: 11.056

5.  Antimicrobial effects of silver nanoparticles.

Authors:  Jun Sung Kim; Eunye Kuk; Kyeong Nam Yu; Jong-Ho Kim; Sung Jin Park; Hu Jang Lee; So Hyun Kim; Young Kyung Park; Yong Ho Park; Cheol-Yong Hwang; Yong-Kwon Kim; Yoon-Sik Lee; Dae Hong Jeong; Myung-Haing Cho
Journal:  Nanomedicine       Date:  2007-03       Impact factor: 5.307

6.  Chitosan nanoparticles enhances the anti-quorum sensing activity of kaempferol.

Authors:  Sedef Ilk; Necdet Sağlam; Mustafa Özgen; Feza Korkusuz
Journal:  Int J Biol Macromol       Date:  2016-10-21       Impact factor: 6.953

7.  Impact of environmental conditions (pH, ionic strength, and electrolyte type) on the surface charge and aggregation of silver nanoparticles suspensions.

Authors:  Amro M El Badawy; Todd P Luxton; Rendahandi G Silva; Kirk G Scheckel; Makram T Suidan; Thabet M Tolaymat
Journal:  Environ Sci Technol       Date:  2010-02-15       Impact factor: 9.028

8.  Kaempferol loaded lecithin/chitosan nanoparticles: preparation, characterization, and their potential applications as a sustainable antifungal agent.

Authors:  Sedef Ilk; Necdet Saglam; Mustafa Özgen
Journal:  Artif Cells Nanomed Biotechnol       Date:  2016-06-06       Impact factor: 5.678

9.  The mechanism of action of Russian propolis ethanol extracts against two antibiotic-resistant biofilm-forming bacteria.

Authors:  J Bryan; P Redden; C Traba
Journal:  Lett Appl Microbiol       Date:  2016-02       Impact factor: 2.858

10.  The use of some nanoemulsions based on aqueous propolis and lycopene extract in the skin's protective mechanisms against UVA radiation.

Authors:  Monica V Butnariu; Camelia V Giuchici
Journal:  J Nanobiotechnology       Date:  2011-02-04       Impact factor: 10.435

View more
  3 in total

Review 1.  The Potential of Honeybee Products for Biomaterial Applications.

Authors:  Martina Rossi; Pasquale Marrazzo
Journal:  Biomimetics (Basel)       Date:  2021-01-15

Review 2.  The Application of Silver to Decontaminate Dental Unit Waterlines-a Systematic Review.

Authors:  Feiruo Hong; Piaopiao Chen; Xuefen Yu; Qianming Chen
Journal:  Biol Trace Elem Res       Date:  2022-01-08       Impact factor: 4.081

3.  Antibacterial Effects of Sodium Borate and Calcium Borate Based Polymeric Coatings for Orthopedic Implants.

Authors:  Huseyin S Coskun; Lokman Kehribar; Serkan Surucu; Mahmud Aydin; Mahir Mahirogullari
Journal:  Cureus       Date:  2022-02-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.